Sage Therapeutics Reports 2024 Financial Results and Insights
Sage Therapeutics Financial Summary for 2024 Sage Therapeutics, Inc. (Nasdaq: SAGE) is delighted to share its financial performance and pipeline advancements for the fourth quarter and full year results concluded at the end of 2024. CEO Barry Greene expressed pride in assisting numerous women grappling with postpartum depression during 2024, highlighting ZURZUVAE's...
Continue Reading